Physician profile
Ajay Jain
NPI 1104853787
$1,587.21
in general payments reported to CMS, 2019-2025
16 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $67.33 · 2021: $120 · 2022: $220 · 2023: $328 · 2024: $420 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.59 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $682.89 | 2019-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor, S-Icd System Magnet |
| Abbott Laboratories | $134.68 | 2019-2021 | |
| Pfizer INC. | $128.12 | 2022-2024 | |
| Novo Nordisk INC | $90.19 | 2024 | |
| Vital Connect, INC | $82.59 | 2022-2023 | Vitalpatch Rtm |
| Lexicon Pharmaceuticals, INC. | $78.92 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $76.82 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.45 | 2024-2025 | |
| Atricure, INC. | $60.43 | 2024 | |
| Baxter Healthcare | $47.98 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Preventice Services, LLC | $41.87 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $34.18 | 2021-2023 | |
| Integra Lifesciences Corporation | $22.00 | 2025 | Integra, Omnigraft, Surgimend |
| Merck Sharp & Dohme LLC | $16.29 | 2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.94 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.86 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.